The European Life Sciences Coalition has been launched in Brussels with the aim of strengthening Europe’s life sciences and ...

Serac Healthcare has received fast track designation from the US Food and Drug Administration for 99mTc‑maraciclatide, a SPECT‑CT imaging agent intended for the visualisation of inflammation in ...

Bioxytran has reported positive results from its completed phase 2 trial of ProLectin‑M, showing rapid and sustained viral clearance in subjects with laboratory‑confirmed acute viral infection. The ...

THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex acquiring rights to develop and commercialise two drug candidates across multiple ...

Re:Cognition Health, a global leader in brain and memory health research, and Cera – Europe’s largest digital‑first home healthcare provider – have announced a new collaboration designed to expand ...

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence for durvalumab, ...

Breye Therapeutics has reported promising early clinical findings for its lead oral therapy danegaptide, following a presentation at the Angiogenesis, Exudation and Degeneration 2026 symposium.

– Panel agreed partnership is essential to tackle system pressures and deliver the 10 year health plan and life sciences ambitions. – Focus on co-design, community engagement and humility as core ...

emc receives over 40 million visits per year, with 72% of HCPs stating this resource as their first-choice source of medicines information. For a deeper look at the survey findings and its ...

What began as a convenience play has evolved into something more consequential: a shift in where trust is built; how ...

Looking across late-stage pharma R&D, three dominant themes emerge for 2026. These reflect a maturing AI landscape, ...